NCT03475433

Brief Summary

This study focuses on whether or not physical activity and sleep quality correlate with the health of prostate and breast cancer patients. The activity data will be acquired using wearable actigraphy devices, which the subjects will wear for the duration of seven days. The sleep quality will be measured using a combination of actigraphy and the mandarin version of the Pittsburgh Sleep Quality Index (PSQI) and the Quality of Life Questionnaire (QLQ). By using this combination, the investigators will not only measure the objective physical activity while the patient is asleep, but also the subjective sleep quality. The questionnaire will also function as control data for the accuracy of the actigraphy device. This study will recruit approximately 30 breast or prostate cancer patients. The participants will wear a wearable actigraphy device for 7 consecutive days, which will provide accurate and objective movement and sleep data. This data is linked to a unique Identification number (ID), which will be noted in the participant's case report. This case report also contains the participant's information and answers to the questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 23, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

April 10, 2019

Status Verified

March 1, 2018

Enrollment Period

3 months

First QC Date

March 5, 2018

Last Update Submit

April 8, 2019

Conditions

Keywords

CancerQuestionnaireSurveySleep DisturbanceSleep QualityE-healthM-healthActigraphyPhysical activityDyssomnias Medical Subject Headings [MeSH]Sleep Wake Disorders [MeSH]Parasomnias [MeSH]Nervous System Diseases [MeSH]Mental Disorders [MeSH]Neurologic Manifestations [MeSH]Signs and Symptoms [MeSH]Telemedicine [MeSH]Actigraphy [MeSH]Quality of Life [MeSH]Motor Activity [MeSH]Breast Neoplasms [MeSH]Prostatic Neoplasms [MeSH]Sleep Hygiene [MeSH]Neoplasms [MeSH]

Outcome Measures

Primary Outcomes (2)

  • Change will be assessed on the quality of life of breast and prostate cancer patients.

    It will be measured using the scores of the Quality of Life questionnaire.

    The time frame will be 8th day after enrolment of each respondent

  • Change will be assessed for the influence of physical activity on the Quality of Life of breast and prostate cancer patients.

    It will be measured using the physical activity data from the actigraphy device.

    The time frame will be daily for 8 days after enrolment of each respondent

Secondary Outcomes (1)

  • Study whether sleep quality and the quality of life scores of breast and prostate cancer patients are correlated

    The time frame will be 8th day after enrollment of each respondent

Study Arms (2)

Beast cancer patients

All participants that suffer from breast cancer.

Device: Actigraphy device

Prostate cancer patients

All participants that suffer from prostate cancer.

Device: Actigraphy device

Interventions

Both groups will receive an actigraphy device that will passively measure their movement data.

Beast cancer patientsProstate cancer patients

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants will be selected with the help of oncologists in Taiwanese hospitals, therefore all participants will be Taiwanese residents and patients of either one of the desired hospital locations in Taipei. All participants are also either breast cancer or prostate cancer patients, with a minimum age of 20 years.

You may qualify if:

  • The patient:
  • Is an outpatient receiving evaluation, treatment, or follow-up care at either one of the desired hospital locations in Taipei.
  • Has been diagnosed with prostate or breast cancer within the past year.
  • Is currently receiving treatment for the cancer.
  • Is at least 20 years old.
  • Is able to understand Mandarin Chinese.
  • Gives informed consent to participate.
  • scores at least 26 on the Mini-Mental State Examination (MMSE).
  • Has a score 45 or higher on the Berg Balance Scale test.

You may not qualify if:

  • The patient:
  • Cannot understand the intent of the study.
  • scores lower than 26 on the Mini-Mental State Examination (MMSE).
  • Is not fit to participate, as believed by their current treating physician.
  • Is physical unable to walk.
  • Has a score of \<45 on the Berg Balance Scale test.
  • Refuses to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Taipei Medical University Hospital

Taipei, Taipei City, 11031, Taiwan

Location

Taipei Municipal Wanfang Hospital

Taipei, Taipei City, 11696, Taiwan

Location

Related Publications (12)

  • Robison LL, Demark-Wahnefried W. Cancer survivorship: focusing on future research opportunities. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1994-5. doi: 10.1158/1055-9965.EPI-11-0837. No abstract available.

    PMID: 21980006BACKGROUND
  • Monga U, Kerrigan AJ, Thornby J, Monga TN. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig. 1999;7(3):178-85. doi: 10.1002/(SICI)1520-6823(1999)7:33.0.CO;2-0.

    PMID: 10406060BACKGROUND
  • Shin WK, Song S, Jung SY, Lee E, Kim Z, Moon HG, Noh DY, Lee JE. The association between physical activity and health-related quality of life among breast cancer survivors. Health Qual Life Outcomes. 2017 Jun 30;15(1):132. doi: 10.1186/s12955-017-0706-9.

    PMID: 28666465BACKGROUND
  • Inbar C, Ety B, Ayala H, Tamer P. The mental health of breast cancer survivors and their adolescent daughters. Psychooncology. 2013 Jun;22(6):1236-41. doi: 10.1002/pon.3127. Epub 2012 Jul 4.

    PMID: 22764063BACKGROUND
  • Toivonen KI, Tamagawa R, Speca M, Stephen J, Carlson LE. Open to Exploration? Association of Personality Factors With Complementary Therapy Use After Breast Cancer Treatment. Integr Cancer Ther. 2018 Sep;17(3):785-792. doi: 10.1177/1534735417753539. Epub 2018 Jan 24.

    PMID: 29361852BACKGROUND
  • Szymlek-Gay EA, Richards R, Egan R. Physical activity among cancer survivors: a literature review. N Z Med J. 2011 Jun 24;124(1337):77-89.

    PMID: 21946880BACKGROUND
  • Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv. 2010 Jun;4(2):87-100. doi: 10.1007/s11764-009-0110-5. Epub 2010 Jan 6.

    PMID: 20052559BACKGROUND
  • Meneses-Echavez JF, Gonzalez-Jimenez E, Ramirez-Velez R. Supervised exercise reduces cancer-related fatigue: a systematic review. J Physiother. 2015 Jan;61(1):3-9. doi: 10.1016/j.jphys.2014.08.019. Epub 2014 Dec 13.

    PMID: 25511250BACKGROUND
  • Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 2002 Nov;24(5):471-80. doi: 10.1016/s0885-3924(02)00500-6.

    PMID: 12547047BACKGROUND
  • Costa AR, Fontes F, Pereira S, Goncalves M, Azevedo A, Lunet N. Impact of breast cancer treatments on sleep disturbances - A systematic review. Breast. 2014 Dec;23(6):697-709. doi: 10.1016/j.breast.2014.09.003. Epub 2014 Oct 11.

    PMID: 25307946BACKGROUND
  • Tsai PS, Wang SY, Wang MY, Su CT, Yang TT, Huang CJ, Fang SC. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005 Oct;14(8):1943-52. doi: 10.1007/s11136-005-4346-x.

    PMID: 16155782BACKGROUND
  • Wan C, Meng Q, Yang Z, Tu X, Feng C, Tang X, Zhang C. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Ann Oncol. 2008 Dec;19(12):2053-60. doi: 10.1093/annonc/mdn417. Epub 2008 Jul 24.

    PMID: 18653703BACKGROUND

Related Links

MeSH Terms

Conditions

Breast NeoplasmsProstatic NeoplasmsNeoplasmsParasomniasSleep Initiation and Maintenance DisordersMotor Activity

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesSleep Wake DisordersNervous System DiseasesMental DisordersSleep Disorders, IntrinsicDyssomniasBehavior

Study Officials

  • Syed Abdul Shabbir, Dr. MD

    Associate Professor & Health IT Consultant

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2018

First Posted

March 23, 2018

Study Start

May 15, 2018

Primary Completion

July 31, 2018

Study Completion

August 31, 2018

Last Updated

April 10, 2019

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will share

All Individual Participant Data (IPD) will be shared as open research data after the results have been published. All data that might identify individuals will be stripped to make sure the data is completely anonymous.

Shared Documents
STUDY PROTOCOL
Time Frame
The anonymous (raw) data might be shared after the study itself has been finished.
Access Criteria
The applications for IPD sharing will be reviewed on an individual basis by the Principal Investigator.

Locations